Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips These days the most popular stocks to follow are either meme plays or the most blue-chip S&P 500 companies. Very few investors seem to be interested in hidden gem stock picks. About halfway through September, the i...
Summary Embecta came in with a solid set of results that demonstrate its resiliency in a weakening economic outlook. Whilst company-level factors are robust for the name, as an investment proposition, metrics aren't as attractive. Shares look to be fairly priced at current ear...
Summary Matrix Asset Advisors is a Value-Driven asset management company. Our investment philosophy and process has allowed us to build a cohesive team of key investment professionals, enabling us to be both opportunistic and responsive. We think the economy is in better shape tha...
PARSIPPANY, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences: The 2022 Wells Fargo Healthcare Conference at the Encore Boston Harbor Hotel in Boston, Mass. ...
Embecta Corp. (EMBC) Q3 2022 Earnings Conference Call August 15, 2022 8:00 AM ET Company Participants Pravesh Khandelwal – Head-Investor Relations Dev Kurdikar – Chief Executive Officer Jake Elguicze – Chief Financial Officer Conference...
Embecta ( EMBC ) declares $0.15/share inaugural quarterly dividend . Forward yield 2.09% Payable Sept. 14; for shareholders of record Aug. 26; ex-div Aug. 25. See EMBC Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: ...
The following slide deck was published by Embecta Corp. in conjunction with their 2022 Q3 earnings call. For further details see: Embecta Corp. 2022 Q3 - Results - Earnings Call Presentation
Markets look to start trading on its back foot but shares of Accelerate Diagnostics, Inc. ( NASDAQ: AXDX ) have exploded nearly 25% after entering an agreement with Becton, Dickinson and Company ( BDX ). Also trading in the green are shares of Embecta Corp. ( NASDAQ: EMB...
Embecta press release ( NASDAQ: EMBC ): Q3 GAAP EPS of $1.07 beats by $0.20 . Revenue of $291.1M (-1.3% Y/Y) beats by $14.24M . Adjusted gross profit and margin of $203.1M and 69.8%, compared to $206.4M and 70.0% in the prior year period. Adjusted EBITDA an...
PARSIPPANY, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world following its April 1, 2022, spin off from Becton, Dickinson and Company (“BD”), today reported financi...
News, Short Squeeze, Breakout and More Instantly...
PARSIPPANY, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal third quarter 2024 financial results, provide an operational upd...
PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at the American Diabetes Association’s 84 th Scientific Sessions that point to ...
2024-06-21 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...